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Background: Medicinal plants have been of great importance to many traditional communities for many 
generations. However, there is need to carry out scientific studies in order to confirm the medicinal properties of 
many plants used traditionally. Carissa edulis Forskk. (Gentiales: Apocynaceae) used by local communities for the 
treatment of various diseases has showed antiviral, antibacterial and antiprotozoal properties although there are no 
studies demonstrating its antileishmanial activity. 
Objective: To investigate in vitro antileishmanial activity of extracts of Carissa edulis on promastigote and amastigote 
forms of Leishmania major. 
Methodology: Solvent extraction of the stem parts of C. edulis was performed using water, methanol, petroleum 
ether, dichloromethane and ethyl acetate. Minimum inhibitory concentration (MIC), anti-amastigote and nitric oxide 
production assays were carried out to demonstrate antileishmanial activity of C. edulis extracts against the two forms 
of L. major parasite species: promastigote and amastigote. The extracts were also screened for phytochemical 
constituents present. Cytotoxicity assay was then done to assess their safe use as herbal medicinal products. 
Results: The C. edulis petroleum ether extract showed the strongest antileishmanial activity against L. major 
promastigotes (MIC=625μg/ml) with the water, dichloromethane and ethyl acetate extracts recording the weakest 
activity (MIC=2500μg/ml). The successive methanol extract reduced the number L. major amastigotes by 88.29% 
compared to the negative control (RPMI). The water (13.37μM), petroleum ether (12.93μM) and successive methanol 
extracts (12.82μM) produced nitrite values lower than the standard drugs Pentostam® (14.35μM) and Amphotericin 
B (14.13μM). 
Discussion: All C. edulis extracts have potential antileishmanial activity against L. major. Preliminary phytochemical 
screening of these extracts showed presence of alkaloids, terpenoids, phenols, anthraquinones and saponins. These 
phytochemicals were previously reported to have antileishmanial activity. Therefore, the plant extracts could offer 
an opportunity to develop cheaper antileishmanial alternatives to the more expensive pentavalent antimonials. 
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1. Introduction 
Leishmaniasis is a vector-borne disease classified as one 
of the neglected tropical diseases amongst 
schistosomiasis, soil-transmitted helminth (STH) 
infections, lymphatic filariasis (LF), human African 
trypanosomiasis (HAT), leprosy, trachoma and 
onchocerciasis (Hotez et al, 2007; Boelaert and Sundar, 
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2013). The disease is endemic in numerous tropical and 
subtropical areas, and is also gaining ground in the 
European Mediterranean area. An estimated 12 million 
people are currently affected worldwide with cases of 
the disease reported from 98 countries in South America, 
Africa, southern Europe and Asia. This figure is thought 
to represent only 30% of the cases since the remaining 
cases go unreported (Desjeux, 2004; Alvar et al, 2012). 
New cases of leishmaniases are estimated to be close to 
2 million per year while the population estimated to be 
at risk worldwide is 350 million (World Health 
Organization, 2010). Leishmania major is the causative 
agent of cutaneous leishmaniasis and its treatment 
remains a challenge. Given that there is still no vaccine 
available for use in humans, chemotherapy has been the 
main method of treatment. The current recommended 
first line of drugs require long courses of medication and 
parenteral administration which have adverse side 
effects. The cost of treatment is also considered quite 
expensive in resource-limited areas (Guerin et al, 2002; 
Dube et al, 2005; Singh, 2006). Recently, the problem of 
drug resistance has emerged in many endemic areas 
(Croft, Sundar, and Fairlamb, 2006). There is need to 
develop alternative treatments which are safer, less 
toxic, less expensive and readily available. 
According to the World Health Organization (WHO), 
around 40% to 60% of the world’s people turn to 
traditional medicine for their health care (Dutta et al, 
2007). Medicinal plants have been of great importance to 
many traditional communities for generations. They are 
virtually used as a primary source of healthcare for a 
wide variety of illnesses and body conditions (Ateş and 
Erdoğrul, 2003; Dulger et al, 2005; Nair, 2005; Şengül et 
al, 2005; Kumar et al, 2006; Mathabe et al, 2006). 
However, there is still a lack of experimental scientific 
studies confirming the medicinal properties of many of 
these remedies. In vitro antileishmanial screening 
methods furnish the preliminary observations that are 
necessary to select, among the plant products, those with 
potentially useful activities for further chemical and 
pharmacological studies. In this study, six solvent 
extracts of Carissa edulis were used for preliminary 
screening of antileishmanial activity against the 
promastigote and amastigote forms of Leishmania major. 
The selection of Carissa edulis was based on data 
obtained from literature, traditional uses of the plant and 
chemical composition of the plant or other plants 
belonging to the same genus. Some of the reported 
infections treated by this plant, such as viral, bacterial, 
fungal and protozoal infections, have a similar 
pathogenic mechanism similar to leishmaniasis (Croft 
and Coombs, 2003; Donald, 2003). 
2. Methodology 
2.1 Study Site 
The study was carried out in the Leishmania laboratory 
of the Centre for Biotechnology Research and 
Development (CBRD) situated at the Kenya Medical 
Research Institute (KEMRI), Nairobi. 
2.2 Study Design 
The in vitro studies were carried out using a comparative 
study design. The efficacy and toxicity of the samples 
were compared with those of Pentostam® and 
Amphotericin B®. Schneider’s insect media was used as a 
negative control in experimental chemotherapeutic 
studies. 
2.3 Plant Collection and Extract Preparation 
The stems parts of Carissa edulis (voucher specimen 
number VNN2013/03) were collected from the leeward 
side of Ngong, Kenya - 25.4Km SW of Nairobi. These were 
identified for authentication by taxonomists of the 
Botany Department Herbarium of the University of 
Nairobi. They were then kept in the KEMRI laboratory 
where the study was done. The plant extracts were 
processed according to the method of Kingondu et al, 
(2009). Briefly, the stems and barks were cut into small 
pieces and air-dried for 14 days under a shed. The dried 
specimens were ground using an electrical mill in 
readiness for extraction. Total extracts of methanol and 
water were the first to be prepared. 
100g of each powder was soaked in absolute methanol 
for 24 hours. The extract was filtered, dried with Na2SO4 
and the solvent removed under vacuum in a rotary 
evaporator at 30-35ºC. For aqueous extraction, 100g of 
ground material in 600ml of water was placed in a water 
bath and maintained at 60ºC for 2 hours. The filtrate was 
freeze-dried, weighed and stored at -20ºC until required 
for use. The extracts were tested for cytotoxicity and in 
vitro anti-parasitic activity against L. major parasites. 
Cold sequential extraction was carried out on plant 
material with distilled organic solvents of increasing 
polarity (petroleum ether > dichloromethane > ethyl 
acetate > methanol). A volume of 600ml of petroleum 
ether was added and flasks placed on a shaker and 
soaked for 48 hours. The residue was filtered using a 
Buchner funnel under vacuum until the sample dried. 
The sample was soaked further with 600ml of petroleum 
ether for 24 hours until the filtrate remained clear. The 
filtrate was then concentrated under vacuum by rotary 
evaporation at 30-35ºC as described by Harborne 
(1994). The concentrate was transferred to a sample 
bottle and dried under vacuum; the weight of the dry 
extract was recorded and stored in universal bottles at a 
temperature of -20ºC until required for bioassay. The 
process was repeated sequentially for dichloromethane, 
ethyl acetate and methanol. The yield percentage of each 
extract was then calculated. The extracts were screened 
for cytotoxicity and in vitro anti-leishmanial activity. 
2.4 Phytochemical Studies 
The plant extracts were screened for the presence of 
different phytochemicals as described by Harborne 
(1998). Briefly, each sample extract was diluted with its 
solvent. A volume of 3µl to 6µl of diluted sample of the 
test extracts was spotted one inch from the bottom and 
an inch from the left hand margin of a pre-coated thin 
layer chromatography plate. Correct labeling was 
ensured to enable observation of the results. When the 
spots were dry, the plates were developed in selected 
mobile solvent phases. Sufficient solvent was poured 
into a chromatography jar to a level of half-inch from the 
bottom. The spotted plates were mounted vertically in 
the jars which were paper lined to saturate the 
atmosphere inside with the solvent phase. The mounting 
was such that the extract spots were just above the 
solvent level. The jars were covered with greased lids 
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and allowed to develop. As the solvent rose by capillarity, 
ascending chromatographic separation was obtained, 
resulting in discrete spots. When the solvent front 
reached a point one inch below the top of each plate, the 
plate was removed from the jar and allowed to dry. The 
separated spots were located by fluorescence under 
ultraviolet light. 
Terpenoids: Terpenoids were located by spraying 
plates with vanillin sulphuric acid and heating in a pre-
heated oven at 110ºC. Presence of terpenoids was 
determined by different spots observed with different 
colours. 
Alkaloids: Plates were sprayed with Dragendoff reagent. 
Presence of alkaloids was determined by orange, brown 
or yellow background spots, or intense yellow colour in 
white background. 
Phenols: Plates were sprayed with 1% ferric chloride 
and 1% potassium ferricyanide. Blue spots were 
observed to determine presence of phenols. 
Anthraquinones: Plates were sprayed with methanolic 
potassium hydroxide. Orange or yellow colours were 
observed, indicating presence of anthraquinones. 
Saponins: To test presence of saponins, a solution of the 
extract in a little water was shaken vigorously in a test 
tube. Any foaming indicated presence of saponins. 
2.5 Experimental Animals 
Eight week old BALB/c mice for macrophage assays 
were obtained from KEMRI’s animal house. All animals 
were of the same sex and uniform size. The experiments 
were done in compliance with Animal Care and Use 
Committee (ACUC) guidelines of KEMRI. 
2.6 Leishmania Parasites 
Leishmania major strain (Strain IDU/KE/83=NLB-144), 
originally isolated from a female P. duboscqi (Beach et al, 
1984), maintained by cryopreservation, in vitro culture 
and periodic passage in BALB/c mice.  
Parasites were cultured in Schneider’s Insect Medium 
(SIM) supplemented with 20% heat-inactivated foetal 
bovine serum, 100µg/ml penicillin G and 100µg/ml 
streptomycin (Hendricks and Wright, 1979) and 
500µg/ml 5-fluorocytosine arabinioside (Kimber et al, 
1981). The cultures were made in T25 sterile disposable 
culture flasks (25ml) and incubated at 25ºC and grown 
to stationary phase to generate infective metacyclic 
promastigotes (Evans et al, 1989). Pentostam® was used 
as a positive control. The metacyclic promastigotes were 
isolated by negative selection using peanut agglutinin 
(Tonui et al, 2004). 
2.7 Preparation of the Test Drugs 
Stock solutions of the fractions were made in culture 
media for antileishmanial assays and re-sterilized by 
filtering through 0.22µm filter flasks in a laminar flow 
hood. If some of the extract was found not to dissolve 
easily in water or media, they were first dissolved in 1% 
dimethyl sulfoxide (DMSO) to avoid solvent carry-over 
(Dorin et al, 2001).  
All prepared drugs were stored at 4ºC and retrieved only 
during use. 
2.8 Bioassays 
2.8.1 MIC (Minimum Inhibitory Concentration) Anti-
Promastigote Assay 
Leishmania major promastigotes (1 x 106 parasites/ml) 
were grown and incubated in Schneider’s Insect Medium 
(SIM) culture media containing different concentrations 
of the test extracts ranging from 1mg/ml to 1µg/ml. Cell 
growth was evaluated by assessment of visibility 
turbidity in order to evaluate MIC. The lowest 
concentration of the samples that prevented growth was 
considered as the MIC. 
2.8.2 Anti-Amastigote Assay 
This was carried out as described by Delorenzi et al, 
(2001). Briefly, peritoneal macrophages were obtained 
from BALB/c mice. The mice were injected with 2% 
starch solution to stimulate macrophage proliferation. 
After 24 hours, they were anaesthetized using 100µl 
pentobarbital sodium (Sagatal®). The body surface was 
disinfected with 70% ethanol. The torso skin was torn 
dorsoventrally to expose the peritoneum. Using a sterile 
syringe and needle, 10ml of sterile cold phosphate-
buffered saline (PBS) was injected into the peritoneum. 
After shaking the mouse, peritoneal macrophages were 
harvested by withdrawing the PBS. The contents were 
transferred into a sterile 50ml centrifuge tube. The 
suspension was centrifugally washed at 2000rpm for 10 
minutes and the pellet resuspended in complete RPMI 
1640 medium. 
Macrophages were adsorbed in 24-well plates and 
allowed to adhere for 4 hours at 37ºC in 5% CO2. Non-
adherent cells were washed with cold PBS and the 
cultures incubated overnight in RPMI. Adherent 
macrophages were infected with a parasite/macrophage 
ratio of 6:1 and further incubated at 37ºC in 5% CO2 for 
4 hours. Free promastigotes were removed by extensive 
washing with PBS and the cultures incubated in RPMI for 
24 hours. Treatment of infected macrophages with the 
samples was done once. Pentostam® was used as a 
positive control drug for comparison of parasite 
inhibition. The medium and drug were replenished daily 
for 3 days. After 5 days, the monolayers were washed 
with PBS at 37ºC, fixed in methanol and stained with 
Geimsa. The number of amastigotes was determined by 
counting at least 100 macrophages in duplicate cultures, 
and the results expressed as infection rate (IR) and 
multiplication index (MI) (Berman and Lee, 1984). The 
infection rate was used in calculations of the Association 
Index (AI). The association indices were determined by 
multiplying the percentages of infected macrophages by 
the number of parasites per infected cell. Association 
indices were interpreted as the number of parasites that 
actually infected the macrophages. 
2.8.3 Nitric oxide Production Assay 
Nitric oxide release in macrophage cultures was 
measured using the Greiss reaction for nitrites 
(Hollzmuller et al, 2002). Briefly, 100µl of the 
supernatants was collected 48 hours after introducing 
the test drug into the culture medium. The assay was 
done in triplicate wells in 96-well microtiter plates. To 
this, 60µl of Greiss Reagent A (1% sulphanilmide in 1.2M 
HCl) was added followed by 60µl of Greiss Reagent B 
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(0.3% N-(1-naphthyl) ethylenediamine). The 
absorbance was measured at 540nm in an enzyme-
linked immunosorbent assay (ELISA) reader. Nitrite 
(NO2-) was calculated from a standard curve constructed 
using sodium nitrite in RPMI. 
2.8.4 Cytotoxicity Studies 
VERO cells were cultured and maintained in Minimum 
Essential Medium (MEM) supplemented with 10% FBS. 
The cells were cultured at 37ºC in 5% CO2 for 24 hours 
by trypsinization, pooled in 50ml vial and in 100µl cells 
suspension (1 x 106 cells/ml) put into 2 wells of rows A-
H in a 96-well microtiter plate for one sample to attach. 
The medium was aspirated off and 150µl of the highest 
concentration (1000µg/ml) of each of the test samples at 
562nm was added into the same row and serially diluted. 
The experimental plates with the cells were incubated 
further at 37ºC for 48 hours. The controls used were cells 
with no extract, medium alone. 10µl MTT reagent was 
added into each well and the cells incubated for 2-4 
hours until a purple precipitate was visible under a 
microscope. The medium together with MTT were 
aspirated after which 100µl of DMSO was added and 
plates shaken for 5 minutes.  
The absorbance was measured for each well at 562nm 
using a micro-titer plate reader (Wang et al, 2006). The 
results were expressed as the concentration at which the 
extract inhibited 50% growth of the cells (IC50). 
2.9 Statistical Analysis 
All experiments were done in triplicate. Statistical 
analysis of the differences between mean values 
obtained from the test extracts compared to the controls 
was done by student’s t-test. ANOVA was used to 
determine the differences between the various test 
extracts. A probability value of p ≤ 0.05 was considered 
to be statistically significant. The custom data analysis 
software program, Chemosen, available at KEMRI was 
used to determine IC50 concentrations. 
3.  Results  
3.1 Yield of plant extracts 
The stems parts of Carissa edulis were successfully 
extracted with water, methanol, petroleum ether, 
dichloromethane and ethyl acetate. The plant extracts 
obtained were screened for cytotoxicity and in vitro 
antileishmanial assays. The water extract was brownish 
in colour and powdery in consistency. The methanol 
extract was greenish in colour and oily in consistency. 
The petroleum ether extract was yellowish in colour and 
oily in consistency. The dichloromethane and ethyl 
acetate extracts were greenish and brownish in colour 
and resinous in consistency. Higher yield of extracts was 
obtained from solvents with high polarity than those 
with low polarity. The crude extracts (water and 
methanol) had higher yields followed by successive 
extracts (Table 1). 
 
Table 1: Percentage yield of solvent extracts of the ground plant materials 
Plant 
% Yield of Extracts (g) 
Water TM PE DCM EA SM 
Carissa edulis 3.66 4.79 0.85 0.33 0.33 1.85 
TM-Total Methanol, PE-Petroleum ether, DCM-Dichloromethane, EA-Ethyl acetate, SM-Successive Methanol 
 
 
    Table 2: Phytochemical screening of six solvent extracts of Carissa edulis 
Phytochemicals 
  
Test Extracts 
Water TM PE DCM EA SM 
Alkaloids ++ - ++ +++ + - 
Terpenoids ++ + +++ +++ + ++ 
Phenols +++ + +++ +++ - + 
Anthraquinones ++ + ++ +++ + ++ 
Saponins ++ - - - - - 
TM-Total Methanol, PE-Petroleum ether, DCM-Dichloromethane, EA-Ethyl acetate, SM-Successive Methanol 
Key: +++ very deep colours with different spots observed 
  ++ medium-coloured spots observed 
  + faint-coloured spots observed 
  - absent 
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3.2 Phytochemical studies 
In this study, the extracts of Carissa edulis were screened 
with the intention of finding out presence or absence of 
different classes of secondary metabolites in the plant 
extracts. From the results tabulated in   
  Table 2, all plant extracts tested positive for more 
than one phytochemical component. The water extract 
showed presence of all phytochemical components 
tested. The dichloromethane extract showed the 
strongest presence of most phytochemicals, except 
saponins. The petroleum ether extract also showed 
strong presence of all phytochemicals, except saponins. 
The ethyl acetate extract showed weak presence of the 
phytochemicals tested, with absence of phenols and 
saponins. Both total and successive methanol extracts 
showed absence of alkaloids and saponins. 
3.3 Bioassays 
3.3.1 MIC (minimum inhibitory concentration) anti-
promastigote assay  
Minimum Inhibitory Concentration (MIC) values for the 
extracts were determined against L. major parasites in 
vitro. These values were also compared to the standard 
drugs used in the study: Pentostam® and Amphotericin 
B®. The C. edulis petroleum ether extract was the most 
active with MIC value of 625μg/ml. This was comparable 
to the standard anti-leishmanial drugs (p<0.05). 
Amphotericin B® showed MIC value of 12.5μg/ml and 
Pentostam® showed MIC value of 25μg/ml. Both total 
and successive methanol extracts showed moderate 
activity with MIC values of 1250μg/ml. The water, 
dichloromethane and ethyl acetate extracts were the 
least active with MIC values of 2500μg/ml. Schneider’s 
Insect Medium (SIM) was considered the negative 
control. The L. major parasites continued dividing and 
proliferating in the media. Thus no anti-leishmanial 
activity against the growth of parasites was recorded. 
3.3.2 Anti-amastigote assay 
The plant extracts were screened for their effect on 
macrophages infected with amastigote forms of L. major 
in vitro. These were compared with two commercial 
standard antileishmanial drugs: Pentostam® and 
Amphotericin B®. RPMI-1640 medium was used as the 
negative control. All plant extracts showed lower activity 
comparable to Pentostam® and Amphotericin B® at all 
concentrations (p<0.05). Of interest also, is the effect of 
these extracts in the reduction of parasites in infected 
macrophages. The successive methanol extract recorded 
a multiplication index (MI) value of 11.71% at a 
concentration of 200μg/ml. It reduced the parasites by 
88.29% when compared to the negative control, RPMI 
(p<0.05). This was significantly better than Pentostam®, 
which recorded a value of 13.16% at a concentration of 
200μg/ml (p<0.05). The water extract recorded the least 
parasite reduction activity at a concentration of 
50μg/ml. Its MI value was 64.08% when compared to 
RPMI (p<0.05), thus reducing the number of parasites by 
35.92% (Figure 1). 
3.3.3 Nitric oxide Production Assay 
Nitric oxide produced by infected macrophages treated 
with the plant extracts was measured using the Greiss 
assay. All extracts produced nitrite values significantly 
lower than Pentostam®, Amphotericin B® and RPMI 
(p<0.05) (Figure 2). The water, petroleum ether and 
successive methanol extracts produced nitrite values of 
13.37μM, 12.93μM and 12.82μM respectively at 
concentration of 200μg/ml. This was comparable to 
Pentostam® and Amphotericin B® which produced 
nitrite values of 14.35μM and 14.13μM respectively at 
concentration of 200μg/ml (p<0.05). The ethyl acetate 
extract produced the least amount of nitrite at 
concentration of 200μg/ml when compared to 
Pentostam®, Amphotericin B® and RPMI (p<0.05). 
3.3.4 Cytotoxicity Assay 
Cytotoxicity test of C. edulis extracts was performed in 
vitro against vero cells to assess their safety.The ethyl 
acetate extract was more toxic (p<0.05) with an IC50 
concentration value at 0.65µg/ml than Amphotericin B® 
(IC50=0.82µg/ml). Its petroleum ether extract recorded 
the least toxic IC50 concentration at 3.69µg/ml (p<0.05) 
(Figure 3). 
 
Figure 1: Infection rates of infected BALB/c macrophages treated with six solvent extracts of Carissa edulis compared 
to commercial standard drugs 
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Figure 2: Nitric oxide produced by infected BALB/c macrophages treated with six solvent extracts of Carissa edulis 
compared to commercial standard drugs 
 
Figure 3: Inhibitory concentration of six solvent extracts of Carissa edulis against vero cells compared to commercial 
standard drugs 
4. Discussion 
In order to evaluate the efficacy and antileishmanial 
activity of medicinal plants, different extractions and 
bioassays are usually carried out (Sofowora, 1993). 
Solvent extraction was used in this study to prepare 
extracts due to its ease of use, efficiency and wide 
applicability (Harborne, 1998). The type of solvent used 
for extraction also plays a significant role in the solubility 
of active compounds contained in the plant extracts. This 
in turn may influence the antileishmanial activities of 
these extracts (Tonthubthimthong et al, 2001). 
Preliminary antileishmanial activity screening of plant 
extracts is usually done using the two forms of the 
Leishmania parasite: the promastigote and amastigote 
forms. Assays using the promastigote form are easy to 
perform due to their easy cultivation and maintenance. 
However, they are seen to only indicate possible 
antileishmanial activity of the test drug. Thus 
preliminary screening of drugs using promastigotes 
needs to be complemented with assays performed using 
amastigotes (Chan-Bacab and Pena-Rodriguez, 2001). To 
perform anti-amastigote assays, the promastigote form 
of the parasite must transform into the amastigote form. 
To achieve this, the promastigotes are transformed into 
amastigotes intracellularly by infecting macrophages of 
monocytic cell lines derived from mice (Teixeira et al, 
2002). 
In this study, preliminary antileishmanial screening of 
Carissa edulis extracts performed on the promastigote 
form of Leishmania major showed that their activity 
against promastigotes is not in relation to their polarity. 
The less polar petroleum ether, polar total methanol and 
successive methanol extracts recorded moderate activity 
while the water and less polar extracts (dichloromethane 
and ethyl acetate) recorded weak activity. The activity of 
these extracts against the amastigote form of L. major 
was seen to be dose-dependent. Higher concentrations of 
C. edulis extracts seemed to reduce the infection rate of 
macrophages. The polar extracts (water, total methanol, 
successive methanol and ethyl acetate) were found to be 
more active than less polar extracts (petroleum ether 
and dichloromethane). At their highest concentrations 
(200µg/ml) all extracts, except petroleum ether, had IR 
values not significantly different to the standard 
reference drug Pentostam at concentration 50µg/ml 
(p>0.05). This trend though did not translate to their 
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multiplication indices. The successive methanol extract 
at a concentration of 200µg/ml reduced the number of 
amastigotes by 88.29% effectively than Pentostam at the 
same concentration (p<0.05). This low MI value could be 
as a result of the successive methanol extract killing the 
parasites and inhibiting the parasite growth (James, 
1995). The petroleum ether and crude (total) methanol 
extracts reduced the number of amastigotes also 
demonstrated good potential activity against L. major 
amastigotes compared to Pentostam and Amphotericin 
B® (p<0.05). The ethyl acetate, water and 
dichloromethane extracts recorded the least MI values. 
The macrophage-based amastigote assay is also a good 
indicator for drugs that may have immunostimulatory 
properties. Macrophages play an important role in the 
killing of Leishmania parasites and control of 
leishmaniasis. Infected macrophages elicit a killing 
mechanism that involves the production of nitric oxide. 
This is measured using the Greiss assay. Nitric oxide is 
therefore a key signaling molecule in host defense 
mechanism against intracellular pathogens (Sternberg et 
al, 1994; David et al, 1997; MacMicking, Xie and Nathan, 
1997; Mosser, 2003). Its production as an important step 
in antileishmanial activity in murine macrophages has 
been documented (Augusto et al, 1996; Leiw et al, 1997; 
Ellis et al, 1998; Louis et al, 1998; Kavoosi et al, 2006). In 
this study, infected macrophages treated with C. edulis 
water extract at a concentration of 200µg/ml produced 
3% (13.37μM) more NO than non-treated macrophages 
containing RPMI-1640 medium (12.98μM) as the 
control. The extract showed good antileishmanial 
activity against amastigotes with an infection rate, 
reducing the number of amastigotes by half. This data 
proposes that the phenols detected in the water extract 
may influence the production of nitric oxide by infected 
macrophages. This action activates the killing 
mechanism of NO against the L. major parasites. A study 
by Mendonça-Filho et al, (2004) reported that phenols 
present in the husk fiber of Cocos nucifera L. (Arecales: 
Arecaceae) induced the production of nitric oxide by 
murine macrophages. Although the successive methanol 
extract showed good potential antileishmanial activity 
against promastigotes and amastigotes, the extract did 
not produce increased levels of NO compared to the 
control (p<0.05). This suggests that the mechanism of 
action of C. edulis successive methanol extract does not 
involve nitric oxide. Its action could involve either killing 
the parasites directly or inhibiting the parasite growth 
due to specific compounds present in the extract. TLC 
visualization reagents aided in screening for the 
presence of active compounds present in C. edulis 
extracts. According to the results, one or more 
compounds were present in the extracts which 
attributed to their antileishmanial activity either 
synergistically or individually. Petroleum ether and 
dichloromethane extracts indicated strong presence of 
terpenoids. Terpenoids are soluble in solvents with low 
polarity (Dzubak et al, 2006). A study done by Ogungbe 
et al, (2013) reported antileishmanial activity of 
terpenoids against L. donovani and L. tropica. Another 
study done by Tan et al, (2002) reported antileishmanial 
activity of terpenoids against L. donovani and L. major. 
The water, petroleum ether and dichloromethane 
extracts showed strong presence of phenols. Although 
antileishmanial activity of phenols has been reported 
(Chen et al, 1994; Koide et al, 2002; Oliver et al, 2003; 
Bodiwala et al, 2007), the water and dichloromethane 
extracts showed weak activity against L. major 
promastigotes. This therefore suggests that the 
phytochemicals did not influence their activity towards 
the parasites. However, these extracts showed good 
activity against L. major amastigotes. This could be due 
to the strong presence of alkaloids in the 
dichloromethane extract, and presence of saponins in 
the water extract. Antileishmanial activity of alkaloids 
has been reported (Fournet et al, 1993; Fournet et al, 
1994; Fournet et al, 1996; Henriques et al, 2001; Ferreira 
et al, 2002; Assmar et al, 2003). There have also been 
reports on antileishmanial activity of saponins (Delmas 
et al, 2000; Maes et al, 2004a; Maes et al, 2004b; Mori et 
al, 2007). 
To assess the potential toxicity of test plants or drugs, 
cell based cytotoxicity tests are performed using 
cultured mammalian cells. The tests therefore indicate 
the degree of safe therapeutic use of these plants. In this 
study, the cytotoxic effect of C. edulis extracts was tested 
on mammalian kidney fibroblast cells (vero cell line) by 
using MTT assay. This colorimetric assay has been 
extensively used in cell proliferation and cytotoxicity 
assays (Berridge et al, 2005). A progressive decrease in 
cytotoxicity of extracts of C. edulis was observed with 
decreasing polarity. The petroleum ether, 
dichloromethane, water, total methanol and successive 
methanol extracts showed no cytotoxicity towards 
growth of vero cells. These extracts also showed good 
potential antileishmanial activity against L. major 
parasites. Therefore, this suggests that they are safe to 
use. The ethyl acetate extract was however toxic to vero 
cells (IC50=0.65µg/ml) despite its potential 
antileishmanial activity against the parasites. Its 
cytotoxicity could be due to presence of terpenoids in the 
extract, which are associated with their cytostatic 
property (Dzubak et al, 2006). 
5. Conclusion 
The results of this study revealed the antileishmanial 
activity of Carissa edulis. The crude (total) and successive 
methanol extracts showed potential activity against 
Leishmania major promastigotes and amastigotes with 
no toxicity reported in mammalian (vero) cells. The 
water and dichloromethane extracts showed potential 
activity against L. major amastigotes with no toxicity 
reports. The petroleum ether extract showed potential 
activity against L. major promastigotes with no toxicity 
reported. The ethyl acetate extract showed potential 
activity against L. major amastigotes, though it was toxic 
to vero cells. The phytochemical screening results also 
shed light on the activity portrayed by these extracts. 
Therefore all C. edulis extracts showed potential 
antileishmanial activity against L. major parasites. 
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